Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada · Delayed Price · Currency is CAD 0.1650
+0.0100 (6.45%)
Aug 10, 2026, 3:45 PM EST
Voyageur Pharmaceuticals Market Cap
Voyageur Pharmaceuticals has a market cap or net worth of CAD 35.08 million as of August 10, 2026. Its market cap has increased by 26.37% in one year.
Market Cap
35.08M
Enterprise Value
34.68M
Revenue
47.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
ChartMarket Cap Chart
Since March 10, 2017, Voyageur Pharmaceuticals's market cap has increased from 4.76M to 35.08M, an increase of 636.89%. That is a compound annual growth rate of 23.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 35.08M | 15.56% |
| Dec 31, 2025 | 30.36M | 130.87% |
| Dec 31, 2024 | 13.15M | 32.12% |
| Dec 29, 2023 | 9.95M | -0.88% |
| Dec 30, 2022 | 10.04M | 9.57% |
| Dec 31, 2021 | 9.16M | 57.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vext Science | 63.16M |
| Planet 13 Holdings | 55.33M |
| LSL Pharma Group | 44.99M |
| BioNxt Solutions | 40.82M |
| C21 Investments | 40.35M |
| ZYUS Life Sciences | 39.86M |
| Optimi Health | 39.51M |
| Rubicon Organics | 37.17M |